60 Million J&J Vax Doses Ruined by Baltimore Factory: Report
Another 10 million doses will be allowed to be distributed with a warning that Emergent BioSolutions’ manufacturing may be faulty.

Justin Tallis/AFP via Getty
Get the Cheat Sheet newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
A Baltimore facility that produced Johnson & Johnson vaccines seemed to have a worse handle on it than previously realized. The U.S. Food and Drug Administration believes 60 million doses of the J&J COVID-19 vaccine produced by Emergent BioSolutions must be tossed due to contamination, according to sources who briefed The New York Times. Another 10 million will be allowed to be distributed with a warning that Emergent’s manufacturing may be faulty. The facility closed in March once the contamination—caused when Emergent mixed an ingredient from AstraZeneca’s vaccine with a batch of J&J’s—led to 100 million doses of the latter being put on hold. No doses administered in the U.S. have come from Emergent but, rather, J&J’s plant in the Netherlands.
The incident is the latest in a series of hiccups involving the one-dose vaccine. This week, states raised concerns of a surplus of doses, which prompted the FDA to extend the vaccines’ expiration date by six weeks.
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation